Mackenzie Financial Corp Sells 108,654 Shares of Lam Research Corporation $LRCX

Mackenzie Financial Corp decreased its stake in Lam Research Corporation (NASDAQ:LRCX) by 6.2% in the third quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 1,631,993 shares of the semiconductor company’s stock after selling 108,654 shares during the quarter. Mackenzie Financial Corp owned about 0.13% of Lam Research worth $218,524,000 at the end of the most recent reporting period.

Several other institutional investors also recently added to or reduced their stakes in the stock. Howard Hughes Medical Institute purchased a new stake in shares of Lam Research during the 2nd quarter worth $27,000. Strategic Wealth Investment Group LLC acquired a new position in shares of Lam Research in the 2nd quarter valued at $29,000. Delos Wealth Advisors LLC acquired a new stake in shares of Lam Research during the second quarter worth about $30,000. Country Trust Bank purchased a new position in shares of Lam Research during the second quarter worth $39,000. Finally, Sound Income Strategies LLC acquired a new position in Lam Research in the third quarter valued at approximately $41,000. Hedge funds and other institutional investors own 84.61% of the company’s stock.

Lam Research Price Performance

Shares of NASDAQ LRCX opened at $215.23 on Wednesday. The company has a current ratio of 2.26, a quick ratio of 1.61 and a debt-to-equity ratio of 0.37. Lam Research Corporation has a twelve month low of $56.32 and a twelve month high of $256.68. The business has a 50 day simple moving average of $222.49 and a 200-day simple moving average of $171.33. The company has a market capitalization of $268.77 billion, a price-to-earnings ratio of 44.10, a price-to-earnings-growth ratio of 2.27 and a beta of 1.77.

Lam Research (NASDAQ:LRCX) last posted its earnings results on Wednesday, January 28th. The semiconductor company reported $1.27 EPS for the quarter, topping the consensus estimate of $1.17 by $0.10. The firm had revenue of $5.34 billion during the quarter, compared to analysts’ expectations of $5.23 billion. Lam Research had a net margin of 30.22% and a return on equity of 62.81%. Lam Research’s quarterly revenue was up 22.1% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.91 EPS. Lam Research has set its Q3 2026 guidance at 1.250-1.450 EPS. As a group, equities research analysts expect that Lam Research Corporation will post 3.71 earnings per share for the current year.

Lam Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, April 8th. Investors of record on Wednesday, March 4th will be given a dividend of $0.26 per share. This represents a $1.04 annualized dividend and a yield of 0.5%. The ex-dividend date of this dividend is Wednesday, March 4th. Lam Research’s payout ratio is presently 21.31%.

Key Lam Research News

Here are the key news stories impacting Lam Research this week:

• Positive Sentiment: IBM partnership announced to advance sub‑1nm logic scaling, covering novel materials, advanced processes and High‑NA EUV techniques — a strategic win that reinforces Lam’s role in next‑generation node toolsets and long‑term TAM expansion. IBM and Lam Research Announce Collaboration
• Positive Sentiment: Barclays raised its firm price target on LRCX to $255 (equal weight) and the bank also boosted chip‑gear spending estimates — both moves support a stronger revenue outlook for wafer‑fab equipment suppliers and lift investor sentiment for Lam. Barclays Price Target Raise
• Positive Sentiment: Inclusion in the S&P 100 (effective March 23) and a sector rebound into semiconductor‑equipment names are drawing flows into LRCX, supporting near‑term demand from passive and active investors. QuiverQuant Coverage
• Positive Sentiment: Short interest fell ~20.7% in February to ~26.1M shares (about 2.1% of float) and days‑to‑cover is ~3.0 — reduced short exposure can remove a source of selling pressure and amplify rally momentum when demand improves. (data summary)
• Neutral Sentiment: Industry note: analysts and outlets are reassessing valuation after a very strong 1‑year run and recent pullback; Lam’s outperformance raises questions about near‑term multiples even as fundamentals remain strong. Valuation Assessment
• Negative Sentiment: Significant insider selling has been reported in recent months (multiple executives selling shares) and some large institutional rebalancing occurred (e.g., UBS trimmed a very large position in Q4 2025) — these can be interpreted as supply signals or portfolio adjustments that cap upside if sustained. Insider & Institutional Activity

Analyst Upgrades and Downgrades

A number of research firms have recently issued reports on LRCX. Summit Insights raised shares of Lam Research from a “hold” rating to a “buy” rating in a report on Thursday, January 29th. Mizuho set a $265.00 price objective on shares of Lam Research in a research report on Wednesday, January 28th. The Goldman Sachs Group set a $262.00 price objective on Lam Research and gave the stock a “buy” rating in a report on Thursday, January 29th. TD Cowen upped their price target on Lam Research from $170.00 to $290.00 and gave the stock a “buy” rating in a research note on Thursday, January 29th. Finally, Bank of America increased their price target on shares of Lam Research from $195.00 to $245.00 and gave the company a “buy” rating in a report on Tuesday, January 13th. One analyst has rated the stock with a Strong Buy rating, twenty-eight have assigned a Buy rating and six have given a Hold rating to the company’s stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $245.35.

Insiders Place Their Bets

In other Lam Research news, CFO Douglas R. Bettinger sold 50,057 shares of the business’s stock in a transaction that occurred on Wednesday, March 4th. The shares were sold at an average price of $224.03, for a total value of $11,214,269.71. Following the completion of the sale, the chief financial officer directly owned 1,081,705 shares of the company’s stock, valued at $242,334,371.15. The trade was a 4.42% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, insider Ava Harter sold 1,500 shares of the company’s stock in a transaction on Wednesday, March 4th. The stock was sold at an average price of $222.66, for a total transaction of $333,990.00. Following the completion of the sale, the insider owned 53,205 shares of the company’s stock, valued at $11,846,625.30. This represents a 2.74% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Insiders sold a total of 130,886 shares of company stock worth $29,658,802 in the last quarter. 0.31% of the stock is currently owned by corporate insiders.

Lam Research Profile

Lam Research Corporation (NASDAQ: LRCX) is a global supplier of wafer fabrication equipment and services to the semiconductor industry. Founded in 1980 by David K. Lam and headquartered in Fremont, California, the company develops and manufactures systems used in multiple stages of semiconductor device production, including thin film deposition, plasma etch, wafer cleaning and related process modules and automation.

Lam’s product portfolio covers core process technologies employed by logic and memory manufacturers, with equipment designed to support advanced-node patterning, 3D NAND and other emerging device architectures.